Southern Medical University Study: Vitamin C Combined with Immunotherapy Breaks Through Lung Cancer Drug Resistance
01 In the treatment of non-small cell lung cancer (NSCLC), a subtype characterized by the deletion of the LKB1 gene has long left clinicians at a loss. These tumors are referred to as “immune deserts”—with almost no trace of anti-cancer T cells, they exhibit near-complete resistance to PD-1/PD-L1 immune checkpoint inhibitors (ICIs), resulting in poor … Read more